Skip to main content

FDA approves idelalisib for three leukemia and lymphoma indications

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
FDA approves idelalisib for three leukemia and lymphoma indications

User login

Username

Password

Reset your password

Type	Lead	score